In India, only endocrinologists, internal medicine specialists, and cardiologists can prescribe GLP-1 weight loss drugs.

MUMBAI, India and WARREN, N.J., Feb. 27, 2026 /PRNewswire/ -- Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087; NSE: CIPLA; and hereafter referred to as "Cipla") today announced ...

IST, the barometer index, the S&P BSE Sensex, fell 534.30 points or 0.70% to 75,500.12. The Nifty 50 index dropped 151.35 points or 0.64% to 23,487.80.

Are you thinking about starting a GLP-1 medication? About 1 in 8 US adults have used GLP-1s to manage diabetes, treat heart ...

New trial finds liraglutide reduces brain shrinkage by nearly 50% in Alzheimer’s patients and slows cognitive decline by up to 18% within a year Researchers at Imperial College London found that ...

Generic Victoza is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older, with Type 2 diabetes mellitus. Lupin is releasing ...

Lupin has launched a generic version of the diabetes medication Liraglutide Injection in the US. The product, bioequivalent to Novo Nordisk's Victoza, serves as an adjunct to diet and exercise for ...

Teva Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration for the first generic GLP-1 medication for weight loss, the Parsippany-based company announced Aug. 28. The ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best strong buy growth stocks to buy now. On August 28, Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced the FDA approval ...